These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17763431)

  • 1. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy.
    Stone KB; Oddis CV; Fertig N; Katsumata Y; Lucas M; Vogt M; Domsic R; Ascherman DP
    Arthritis Rheum; 2007 Sep; 56(9):3125-31. PubMed ID: 17763431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
    Wilkes MR; Sereika SM; Fertig N; Lucas MR; Oddis CV
    Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity.
    Targoff IN; Reichlin M
    J Immunol; 1987 May; 138(9):2874-82. PubMed ID: 3553328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis.
    Kryštůfková O; Hulejová H; Mann HF; Pecha O; Půtová I; Ekholm L; Lundberg IE; Vencovský J
    Arthritis Res Ther; 2018 Jul; 20(1):158. PubMed ID: 30053824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
    Mimori T; Imura Y; Nakashima R; Yoshifuji H
    Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.
    Aggarwal R; Oddis CV; Goudeau D; Koontz D; Qi Z; Reed AM; Ascherman DP; Levesque MC
    Rheumatology (Oxford); 2016 Jun; 55(6):991-9. PubMed ID: 26888854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells.
    Barbasso Helmers S; Englund P; Engström M; Ahlin E; Fathi M; Janciauskiene S; Heimbürger M; Rönnelid J; Lundberg IE
    Arthritis Rheum; 2009 Aug; 60(8):2524-30. PubMed ID: 19644880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary fibrosis and myositis in a child with anti-Jo-1 antibody.
    Chmiel JF; Wessel HU; Targoff IN; Pachman LM
    J Rheumatol; 1995 Apr; 22(4):762-5. PubMed ID: 7791178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent occurrence of anti-tRNA(His) autoantibodies that recognize a conformational epitope in sera of patients with myositis.
    Brouwer R; Vree Egberts W; Jongen PH; van Engelen BG; van Venrooij WJ
    Arthritis Rheum; 1998 Aug; 41(8):1428-37. PubMed ID: 9704641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies.
    Miller FW; Twitty SA; Biswas T; Plotz PH
    J Clin Invest; 1990 Feb; 85(2):468-75. PubMed ID: 1688885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Clinical Associations of Anti-Nuclear Matrix Protein 2 Autoantibodies in Patients With Idiopathic Inflammatory Myopathies.
    Yang H; Lu X; Peng Q; Jiang W; Shi J; Zhang Y; Chen H; Wang G
    Arthritis Rheumatol; 2018 Aug; 70(8):1288-1297. PubMed ID: 29534337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.
    Mielnik P; Wiesik-Szewczyk E; Olesinska M; Chwalinska-Sadowska H; Zabek J
    Autoimmunity; 2006 May; 39(3):243-7. PubMed ID: 16769658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
    Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and misdiagnosis of anti-Jo-1 syndrome: analysis of 33 cases].
    Zheng WJ; Wei W; Tang FL
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1565-8. PubMed ID: 14642109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and prognostic associations of anti-Jo-1 antibody levels in patients with antisynthetase syndrome.
    Yang H; Chen Q; Sun C; Jin Q; Zhang L; Liu Q; Peng Q; Wang G; Lu X
    Respir Res; 2024 May; 25(1):222. PubMed ID: 38811943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis.
    Levine SM; Raben N; Xie D; Askin FB; Tuder R; Mullins M; Rosen A; Casciola-Rosen LA
    Arthritis Rheum; 2007 Aug; 56(8):2729-39. PubMed ID: 17665459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope mapping of the cloned human autoantigen, histidyl-tRNA synthetase. Analysis of the myositis-associated anti-Jo-1 autoimmune response.
    Ramsden DA; Chen J; Miller FW; Misener V; Bernstein RM; Siminovitch KA; Tsui FW
    J Immunol; 1989 Oct; 143(7):2267-72. PubMed ID: 2476503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.
    Rönnelid J; Barbasso Helmers S; Storfors H; Grip K; Rönnblom L; Franck-Larsson K; Nordmark G; Lundberg IE
    Autoimmun Rev; 2009 Sep; 9(1):58-61. PubMed ID: 19285154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.